Meeting
2023 ASCO Genitourinary Cancers Symposium
Tumor transcriptomic profiling of patients (pts) with metastatic castration sensitive prostate cancer (mCSPC) who do versus who do not achieve an optimal PSA response to intensified androgen deprivation therapy (i-ADT).
Authors
Vinay Mathew Thomas
Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
Vinay Mathew Thomas , Nicolas Sayegh , Beverly Chigarira , Georges Gebrael , Yeonjung Jo , Nishita Tripathi , Roberto Nussenzveig , Haoran Li , Kamal Kant Kant Sahu , Clara Tandar , Divyam Goel , Puja Iyer , Benjamin L. Maughan , Umang Swami , Neeraj Agarwal
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 234)
DOI
10.1200/JCO.2023.41.6_suppl.234
Abstract #
234
Poster Bd #
H18
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Survival outcomes and characterization of patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) undergoing intensified androgen deprivation therapy (ADT) who do not achieve an optimal PSA response (PSA ≤0.2 ng/mL).
First Author: Nicolas Sayegh
Poster
2024 ASCO Genitourinary Cancers Symposium
Differential treatment effect on overall survival (OS) based on early prostate-specific antigen (PSA) response in metastatic hormone-sensitive prostate cancer (mHSPC): A secondary analysis of TITAN trial.
First Author: Soumyajit Roy
Poster
2023 ASCO Annual Meeting
Prostate-specific antigen value at 3 & 7 months (PSA-3mo, PSA-7mo) and overall survival (OS) in metastatic hormone-sensitive prostate cancer (mHSPC) treated with androgen deprivation (ADT) with or without orteronel (SWOG S1216).
First Author: Mamta Parikh
Poster
2023 ASCO Genitourinary Cancers Symposium
Deep prostate-specific antigen response and overall survival in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis.
First Author: Syed Arsalan Ahmed Naqvi